No Increased Mortality Risks Seen in Japanese AD Patients on Antipsychotics: Study

No increased risk of deaths was observed in Japanese Alzheimer’s disease (AD) patients receiving antipsychotic agents, according to the final report of a large-scale prospective cohort study in Japan, dubbed J-CATIA. The study showed no difference in mortality rates between...read more